HK1214590A1 - 哌啶和哌嗪衍生物 - Google Patents

哌啶和哌嗪衍生物

Info

Publication number
HK1214590A1
HK1214590A1 HK16102449.5A HK16102449A HK1214590A1 HK 1214590 A1 HK1214590 A1 HK 1214590A1 HK 16102449 A HK16102449 A HK 16102449A HK 1214590 A1 HK1214590 A1 HK 1214590A1
Authority
HK
Hong Kong
Prior art keywords
derivativs
piperazine
piperidine
piperazine derivativs
Prior art date
Application number
HK16102449.5A
Other languages
English (en)
Inventor
Sergio Cesco-Cancian
Hongfeng Chen
Jeffrey S Grimm
Neelakandha S Mani
Christopher M Mapes
David C Palmer
Daniel J Pippel
Kirk L Sorgi
Tong Xiao
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41464882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1214590(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1214590A1 publication Critical patent/HK1214590A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/22—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HK16102449.5A 2008-06-30 2016-03-03 哌啶和哌嗪衍生物 HK1214590A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7675208P 2008-06-30 2008-06-30

Publications (1)

Publication Number Publication Date
HK1214590A1 true HK1214590A1 (zh) 2016-07-29

Family

ID=41464882

Family Applications (4)

Application Number Title Priority Date Filing Date
HK11111216.2A HK1156857A1 (zh) 2008-06-30 2011-10-19 取代的嘧啶衍生物的製備方法
HK15101911.7A HK1201441A1 (zh) 2008-06-30 2015-02-26 取代的嘧啶衍生物的製備方法
HK16102449.5A HK1214590A1 (zh) 2008-06-30 2016-03-03 哌啶和哌嗪衍生物
HK16103405.5A HK1215434A1 (zh) 2008-06-30 2016-03-23 取代的嘧啶衍生物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK11111216.2A HK1156857A1 (zh) 2008-06-30 2011-10-19 取代的嘧啶衍生物的製備方法
HK15101911.7A HK1201441A1 (zh) 2008-06-30 2015-02-26 取代的嘧啶衍生物的製備方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16103405.5A HK1215434A1 (zh) 2008-06-30 2016-03-23 取代的嘧啶衍生物

Country Status (36)

Country Link
US (6) US8309720B2 (zh)
EP (5) EP2924025A1 (zh)
JP (1) JP5416768B2 (zh)
KR (1) KR101675354B1 (zh)
CN (1) CN102137672B (zh)
AR (1) AR072396A1 (zh)
AU (1) AU2009267156B2 (zh)
BR (1) BRPI0913644A2 (zh)
CA (1) CA2729733C (zh)
CO (1) CO6341560A2 (zh)
CY (1) CY1116134T1 (zh)
DK (1) DK2310012T3 (zh)
EA (1) EA019361B1 (zh)
EC (1) ECSP11010745A (zh)
ES (1) ES2538135T3 (zh)
HK (4) HK1156857A1 (zh)
HR (1) HRP20150576T1 (zh)
HU (1) HUE024949T2 (zh)
IL (4) IL210214A (zh)
JO (1) JO3043B1 (zh)
ME (1) ME02154B (zh)
MX (1) MX2011000080A (zh)
MY (1) MY150601A (zh)
NI (1) NI201000232A (zh)
NZ (1) NZ590170A (zh)
PE (1) PE20110163A1 (zh)
PL (1) PL2310012T3 (zh)
PT (1) PT2310012E (zh)
RS (1) RS53985B1 (zh)
SI (1) SI2310012T1 (zh)
SV (1) SV2011003788A (zh)
TW (3) TWI498326B (zh)
UA (1) UA106724C2 (zh)
UY (1) UY31949A (zh)
WO (1) WO2010002774A1 (zh)
ZA (1) ZA201100759B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101054325B1 (ko) 2006-03-31 2011-08-04 얀센 파마슈티카 엔.브이. 히스타민 ｈ４ 수용체 조절제로서의 벤조이미다졸―２―일 피리미딘 및 피라진
PL2310012T3 (pl) * 2008-06-30 2015-08-31 Janssen Pharmaceutica Nv Sposób wytwarzania podstawionych pochodnych pirymidyny
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
JP5574294B2 (ja) * 2010-11-04 2014-08-20 独立行政法人科学技術振興機構 光磁気記録媒体及び光磁気記録方法
MY180726A (en) 2013-03-06 2020-12-08 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
EP3124470B1 (en) * 2014-03-28 2020-01-08 Kaneka Corporation Method for producing tri-carbobenzoxy-arginine
ES2902527T3 (es) 2016-11-03 2022-03-28 Bristol Myers Squibb Co Derivados biciclo heterocíclicos sustituidos, útiles como inhibidores del canal ROMK

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005852A (en) 1959-12-22 1961-10-24 Gen Aniline & Film Corp Production of sulfoxides and sulfones
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4191828A (en) * 1976-04-14 1980-03-04 Richardson-Merrell Inc. Process for preparing 2-(2,2-dicyclohexylethyl)piperidine
US4190601A (en) * 1978-05-31 1980-02-26 Union Carbide Corporation Production of tertiary amines by reductive alkylation
JPS5942396A (ja) * 1982-09-02 1984-03-08 Ishihara Sangyo Kaisha Ltd リン酸アミド誘導体およびそれらを含有する殺虫、殺ダニ、殺線虫剤
JPS6130576A (ja) 1984-07-24 1986-02-12 Ube Ind Ltd ２−アミノ−５−シアノピリミジンの製法
CA2144762A1 (en) * 1992-10-14 1994-04-28 George D. Hartman Fibrinogen receptor antagonists
GB9422391D0 (en) 1994-11-05 1995-01-04 Solvay Interox Ltd Oxidation of organosulphur compounds
EA200000840A1 (ru) * 1998-02-17 2001-02-26 Туларик, Инк. Антивирусные производные пиримидина
GB9914258D0 (en) * 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
HUP0202678A3 (en) * 1999-09-30 2004-06-28 Pfizer Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines, pharmaceutical compositions containing them and their use
PL362686A1 (en) 2000-07-21 2004-11-02 Syngenta Participations Ag Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US20030130264A1 (en) 2001-02-16 2003-07-10 Tularik Inc. Methods of using pyrimidine-based antiviral agents
JP2004525150A (ja) * 2001-03-30 2004-08-19 スミスクライン ビーチャム コーポレーション 治療用化合物としてのピラゾロピリジン類の使用
ATE323706T1 (de) * 2001-12-17 2006-05-15 Smithkline Beecham Corp Pyrazolopyridazinderivate
TWI270542B (en) 2002-02-07 2007-01-11 Sumitomo Chemical Co Method for preparing sulfone or sulfoxide compound
ATE440827T1 (de) * 2002-12-04 2009-09-15 Ore Pharmaceuticals Inc Melanocortin-rezeptormodulatoren
JP2006525261A (ja) * 2003-05-05 2006-11-09 エフ．ホフマン−ラ　ロシュ　アーゲー Ｃｒｆ活性を有する縮合ピリミジン誘導体
US7786291B2 (en) 2004-10-27 2010-08-31 Schering Corporation Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
US20060281712A1 (en) 2005-06-14 2006-12-14 Chi-Feng Yen Pyrimidine compounds
BRPI0612720B1 (pt) * 2005-07-06 2016-02-10 Ge Healthcare Bio Sciences Ab método de preparação de uma matriz de separação
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
CN101032483B (zh) * 2006-03-09 2011-05-04 陈德桂 调节雄激素受体活性的乙内酰脲衍生物及其应用
JP2009532367A (ja) * 2006-03-31 2009-09-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンｈ４受容体のモジュレーターとしてのベンゾイミダゾール−２−イルピリジン
KR101054325B1 (ko) * 2006-03-31 2011-08-04 얀센 파마슈티카 엔.브이. 히스타민 ｈ４ 수용체 조절제로서의 벤조이미다졸―２―일 피리미딘 및 피라진
PL2310012T3 (pl) 2008-06-30 2015-08-31 Janssen Pharmaceutica Nv Sposób wytwarzania podstawionych pochodnych pirymidyny
US20100029942A1 (en) * 2008-06-30 2010-02-04 Sergio Cesco-Cancian Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives

Also Published As

Publication number Publication date
HK1156857A1 (zh) 2012-06-22
US20130053561A1 (en) 2013-02-28
US8309720B2 (en) 2012-11-13
US20130225816A1 (en) 2013-08-29
PT2310012E (pt) 2015-04-02
AU2009267156A1 (en) 2010-01-07
TW201012810A (en) 2010-04-01
TWI498326B (zh) 2015-09-01
EP2924025A1 (en) 2015-09-30
HK1201441A1 (zh) 2015-09-04
AU2009267156B2 (en) 2015-05-28
PL2310012T3 (pl) 2015-08-31
UA106724C2 (uk) 2014-10-10
MY150601A (en) 2014-01-30
NI201000232A (es) 2011-09-07
EP2310012A1 (en) 2011-04-20
US20140066624A1 (en) 2014-03-06
US9359327B2 (en) 2016-06-07
US20100004450A1 (en) 2010-01-07
BRPI0913644A2 (pt) 2015-11-24
AR072396A1 (es) 2010-08-25
CN102137672A (zh) 2011-07-27
SI2310012T1 (sl) 2015-06-30
DK2310012T3 (da) 2015-03-30
EP2310012A4 (en) 2012-06-20
IL235570A (en) 2016-08-31
TW201420583A (zh) 2014-06-01
CO6341560A2 (es) 2011-11-21
CN102137672B (zh) 2014-03-26
CA2729733A1 (en) 2010-01-07
MX2011000080A (es) 2011-03-02
CY1116134T1 (el) 2017-02-08
HUE024949T2 (en) 2016-02-29
EP2310012B1 (en) 2015-03-04
HK1215434A1 (zh) 2016-08-26
JO3043B1 (ar) 2016-09-05
US9079883B2 (en) 2015-07-14
NZ590170A (en) 2012-04-27
RS53985B1 (en) 2015-10-30
JP2011526910A (ja) 2011-10-20
SV2011003788A (es) 2011-02-08
IL210214A (en) 2016-07-31
US9079882B2 (en) 2015-07-14
ZA201100759B (en) 2012-07-25
HRP20150576T1 (hr) 2015-09-11
US9006432B2 (en) 2015-04-14
EP2769721A3 (en) 2015-04-01
ES2538135T3 (es) 2015-06-17
CA2729733C (en) 2016-10-25
WO2010002774A1 (en) 2010-01-07
US9079884B2 (en) 2015-07-14
UY31949A (es) 2010-01-29
EP2769721A2 (en) 2014-08-27
EP2924023A1 (en) 2015-09-30
JP5416768B2 (ja) 2014-02-12
IL235572A (en) 2016-09-29
TWI481603B (zh) 2015-04-21
PE20110163A1 (es) 2011-03-28
EA201170113A1 (ru) 2011-08-30
US20140073795A1 (en) 2014-03-13
EA019361B1 (ru) 2014-03-31
ECSP11010745A (es) 2011-02-28
ME02154B (me) 2015-10-20
IL210214A0 (en) 2011-03-31
KR20110023901A (ko) 2011-03-08
US20140121374A1 (en) 2014-05-01
TW201433568A (zh) 2014-09-01
IL235571A (en) 2016-09-29
EP2924035A1 (en) 2015-09-30
KR101675354B1 (ko) 2016-11-11

Similar Documents

Publication Publication Date Title
HK1196358A1 (zh) 取代的吡啶- -酮和噠嗪- -酮
HK1145677A1 (zh) 取代的哌啶子基-二氫噻吩並嘧啶
ZA201107985B (en) Piperidine and piperazine derivatives as autotaxin inhibitors
EP2120573A4 (en) DERIVATIVES OF PIPERIDINE
BRPI0817644A2 (pt) Derivados de piperidina e piperazina
IL210804A (en) Benzylidenehydrazides and their uses
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
EP2285217A4 (en) CONNECTIONS TO IMPROVE LEARNING AND MEMORY
HK1214590A1 (zh) 哌啶和哌嗪衍生物
HK1140198A1 (en) Piperidine compounds and uses thereof
GB0808575D0 (en) Compilign and linking
IL202666A0 (en) Substituted piperazines
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
IL215901A0 (en) Substituted piperidines
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
ZA201204347B (en) New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
HK1171450A1 (zh) 取代的哌啶
IL207315A0 (en) Piperidine derivative
SI2307389T1 (sl) Derivat diabenzotiazepina in njegova uporaba
IL208824A0 (en) Iminopyridine derivative and use thereof
ZA201000917B (en) Piperidine derivative
EP2184272A4 (en) PIPERAZINE DERIVATIVE
EP2274294A4 (en) 5-DIMETHOXY FUMAGILLOL AND ITS DERIVATIVES